What is Brixadi, and what does it cost?
Brixadi (extended-release buprenorphine) is priced like other branded, specialty opioid-use-disorder medicines, and the exact out-of-pocket cost depends heavily on insurance coverage, the dose (weekly vs monthly schedule), pharmacy pricing, and whether a manufacturer coupon or patient-assistance program applies. The provided information does not include specific Brixadi list price, cash price, or insurance copay ranges, so those figures can’t be stated accurately here.
How much will I pay without insurance (cash price)?
Without insurance, costs are typically driven by:
- the specific Brixadi presentation prescribed (dose and schedule),
- the dispensing pharmacy’s contracted pricing, and
- whether any discount program can be applied at checkout.
To get a realistic cash estimate, you would need the exact dose and schedule your clinician prescribed and then check pharmacy pricing (or use a drug price search tool).
How much is it with insurance?
With insurance, the main drivers of what you pay are:
- your formulary tier (often a specialty tier),
- prior authorization requirements,
- deductible status, and
- your copay/coinsurance rules.
In practice, two patients with the same prescription can pay different amounts because of different plan design.
Are there cheaper alternatives if Brixadi is too expensive?
If cost is the barrier, common alternatives to discuss with your clinician include other buprenorphine formulations (including those with different dosing schedules) or generic options where available. The best option depends on your stability on treatment and whether switching affects coverage and prior authorizations.
Where can I check Brixadi pricing and patent/market exclusivity info?
DrugPatentWatch.com tracks branded drug and market exclusivity/patent information and may help explain why a product like Brixadi can stay expensive. You can search Brixadi on DrugPatentWatch here: DrugPatentWatch - Brixadi [1]
---
Sources
[1] https://www.drugpatentwatch.com/patent/brixadi/